Neoplasia/BPH

	Comparison of inflammation-based biomarkers in metastatic testicular cancer at initial diagnosis. Can Urol Assoc J Hacibey I, Ozer E, Demiriz B, Nisli O, Akalin B, Ozdemir H, Canat HL. PMID: 42758921 [PubMed]
	Quantitative MRI for World Health Organisation/International Society of Urological Pathology Grading of Renal Cell Carcinoma: a systematic review and diagnostic meta-analysis. Eur Radiol Kiani I, Fujiwara M, Mohammadzadeh S, Pourakbar N, Kwee TC, Masuyama S, Nissan N, Woo S, Yoshida S, Arita Y. PMID: 42758284 [PubMed - as supplied by publisher]
	Impact of resection bed management on postoperative outcomes after Robot-Assisted Partial Nephrectomy : a retrospective French Nationwide Study (UroCCR 215). World J Urol Paillusson D, Margue G, Champy C, Doumerc N, Bigot P, Bruyere F, Paparel P, Surlemont L, Olivier J, Durand M, Branger N, Waeckel T, Fontenil A, Vallee M, Ouzaid I, Patard JJ, Guillotreau J, Panthier F, Belas O, Boissier R, Taha F, Letang N, Parier B, Lang H, Dameron C, Verhoest G, Sarrazin C, Bernhard JC, Bobet S, Karakachoff M, de Vergie S. PMID: 42758231 [PubMed - indexed for MEDLINE]
	Isolated MSH2 Loss With Divergent Microsatellite Instability Status in Colorectal and Prostate Adenocarcinoma: A Diagnostic Pitfall. Int J Surg Pathol Kakodkar P, Wang H. PMID: 42757994 [PubMed - as supplied by publisher]
	MR Virtual Cytometry for Zone-specific Prostate Cancer Characterization with Histologic and Molecular Validation. Radiol Imaging Cancer Lu J, Cheng H, Li H, Liu K, Xu H, Ba R, Liu M, Zhang W, Zhu H, Chen M, Li C, Wu D. PMID: 42757967 [PubMed - indexed for MEDLINE]
	Eomesodermin in renal cell carcinoma: Epigenetic and immune crosstalk driving tumor progression (Review). Int J Oncol Che Z, Huang D, Lin J, Wang X, Feng R, Che X, Wang Y. PMID: 42757465 [PubMed - indexed for MEDLINE]
	Bridging the Resolution Gap in Recurrent Prostate Cancer Imaging: Quantum Dots as PSMA-Targeted Optical Probes. ACS Omega Gidiya Y, Chaudhary J, Biswas A, Liao M, Ramaroson M, Kamei KI. PMID: 42757093 [PubMed]
	Diagnostic challenges in a rare case of bladder metastasis from lung hepatoid adenocarcinoma: The first reported case. Urol Case Rep Mesmoudi S, Benazzouz MH, Derqaoui S, Aaboudech TY, Bernoussi Z, Znati K. PMID: 42757010 [PubMed]
	Perioperative cognitive dysfunction in bladder cancer patients, causal factors, and possible interventions. Front Med (Lausanne) Cicvaric A, Glavas Tahtler J, Pavlovic O, Dias C, Tot OK, Bjelousov Baksa A, Kvolik S. PMID: 42756876 [PubMed]
	Cost-utility of NeuroSAFE-guided RARP Versus Standard RARP in Men with Localised Prostate Cancer in the UK. Eur Urol Open Sci Wang J, Almeida-Magana R, Dinneen E, Pan S, Leurent B, Roberts N, Brew-Graves C, Williams NR, Haider A, Shaw G, Pizzo E. PMID: 42755911 [PubMed]
	Adjuvant therapy in chromophobe renal cell carcinoma: current evidence and unmet needs. Front Oncol Bejjani N, Kattan J. PMID: 42755866 [PubMed]
	Performance evaluation of large language models in bladder cancer patient education Q&A: a cross-sectional study. Front Oncol Wan D, Li Y, Dong Z, Dai C, Ye J, Li S, Jiang S. PMID: 42755637 [PubMed]
	Antidiabetic drug exposure and risk of bladder cancer: A systematic review and meta-analysis. Urologia Mathez W, Vincentelli A, Chaoui I, Bruyère F, Bourgi A. PMID: 42755180 [PubMed - as supplied by publisher]
	Perioperative outcomes and prevalence of urethral strictures during surgery for benign prostatic hyperplasia: results from the GRAND study. World J Urol Pyrgidis N, Schulz GB, Weinhold P, Volz Y, Atzler M, Stadelmeier LF, Papadopoulos I, Stief C, Marcon J, Keller P. PMID: 42754713 [PubMed - indexed for MEDLINE]
	Prognostic value and immune landscape implications of using a novel homologous recombination repair pathway signature in prostate cancer: A retrospective cohort study. J Int Med Res Wang F, Tian YE, Liu Q, Sha MO, Wang P, Huang X, Tuoheti K, Chen J, Cui QI. PMID: 42754412 [PubMed - indexed for MEDLINE]
	From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX-Targeted [(68)Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter Comparison with [(18)F]FDG PET/CT. J Nucl Med Kömek H, Arslan E, Can C, Akgün E, K, Yüceta, Akdeniz N, Çermik TF, Urakç, Do, Bardakç, Yeprem Ö, Kural AR. PMID: 42754347 [PubMed - as supplied by publisher]
	Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives. J Immunol Res Shi R, Ran L, Song T, Zhou X, Zhao W, Zhang Y. PMID: 42753002 [PubMed - indexed for MEDLINE]
	Safety and patient-reported outcomes of multimodal PSMA PET/MRI-guided prostate biopsy: results from the prospective multicenter DEPROMP trial. World J Urol Schmidt CJ, Reichert T, Gaertner FC, Kreppel B, Essler M, Luetkens JA, Attenberger U, Anspach M, Ohlmann CH, Hauser S, Ellinger J, Ritter M, Krausewitz P. PMID: 42752988 [PubMed - indexed for MEDLINE]
	Multimodal large language models for bladder tumor detection in cystoscopy: a retrospective benchmarking study. World J Urol Prat Y, Mahmud H, Tsur A, Laufer M, Orkin D, Dotan ZA, Rosenzweig B. PMID: 42752986 [PubMed - indexed for MEDLINE]
	Night work and cancer risk: results from the ELSA-Brasil worker cohort. Rev Saude Publica Bernardino DCAM, Otero UB, Pimenta IT, Griep RH, Giatti L, Barreto SM, Fonseca MJMD. PMID: 42752711 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 191354

Page 1 of 9568



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy